Home/Filings/4/0001209191-15-066077
4//SEC Filing

EnteroMedics Inc 4

Accession 0001209191-15-066077

CIK 0001371217operating

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 4:26 PM ET

Size

27.2 KB

Accession

0001209191-15-066077

Insider Transaction Report

Form 4
Period: 2015-08-12
KNUDSON MARK B
DirectorChrmn, Pres & CEO
Transactions
  • Purchase

    Common Stock

    2015-08-12$0.24/sh+135,000$32,913135,000 total
  • Purchase

    Common Stock

    2015-08-13$0.25/sh+168,000$41,798303,000 total
Holdings
  • Common Stock

    (indirect: By Trust)
    1,382
  • Common Stock

    (indirect: By Partnership)
    3,215
  • Common Stock

    (indirect: By Trust)
    57,571
  • Stock Option (right to buy)

    Exercise: $2.76Exp: 2015-04-27Common Stock (7,915 underlying)
    7,915
  • Stock Option (right to buy)

    Exercise: $2.76Exp: 2016-04-20Common Stock (6,776 underlying)
    6,776
  • Stock Option (right to buy)

    Exercise: $1.90From: 2010-10-29Exp: 2017-10-29Common Stock (33,432 underlying)
    33,432
  • Stock Option (right to buy)

    Exercise: $1.90From: 2010-10-29Exp: 2017-10-29Common Stock (25,902 underlying)
    25,902
  • Stock Option (right to buy)

    Exercise: $1.90From: 2010-10-29Exp: 2017-10-29Common Stock (50,472 underlying)
    50,472
  • Stock Option (right to buy)

    Exercise: $3.78Exp: 2019-11-18Common Stock (20,833 underlying)
    20,833
  • Warrant (common stock right to buy)

    Exercise: $2.19Common Stock (25,000 underlying)
    25,000
  • Stock Option (right to buy)

    Exercise: $2.58From: 2011-03-16Exp: 2021-02-16Common Stock (350,000 underlying)
    350,000
  • Stock Option (right to buy)

    Exercise: $2.67From: 2011-08-12Exp: 2021-07-12Common Stock (350,000 underlying)
    350,000
  • Stock Option (right to buy)

    Exercise: $1.90From: 2012-01-14Exp: 2021-12-14Common Stock (200,000 underlying)
    200,000
  • Stock Option (right to buy)

    Exercise: $1.31From: 2013-06-30Exp: 2013-05-31Common Stock (1,278,730 underlying)
    1,278,730
  • Stock Option (right to buy)

    Exercise: $1.90From: 2010-10-29Exp: 2017-10-29Common stock (44,131 underlying)
    44,131
  • Stock Option (right to buy)

    Exercise: $3.35From: 2012-08-10Exp: 2022-07-10Common Stock (1,292,225 underlying)
    1,292,225
  • Stock Option (right to buy)

    Exercise: $1.11From: 2015-04-09Exp: 2025-03-09Common Stock (225,000 underlying)
    225,000
Footnotes (8)
  • [F1]The price reported is the weighted average purchase price for the transaction reported. The purchase prices ranged from $0.2349 to $0.2500. The Reporting Person will provide to the issuer, a security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range.
  • [F2]The price reported is the weighted average purchase price for the transaction reported. The purchase prices ranged from $0.2475 to $0.2490. The Reporting Person will provide to the issuer, a security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range.
  • [F3]Options currently 100% vested.
  • [F4]Options vest 33% on date noted and thereafter at 1/24th per month.
  • [F5]Warrant becomes exercisable 181 days from the date of issuance at close of offering.
  • [F6]Warrant expires five years from the date it becomes exercisable.
  • [F7]Vests in increments of 1/48th per month, beginning the date shown.
  • [F8]The exercise price is the closing price on July 10, 2012, the date the board authorized the grants subject to stockholder approval of the increase in the number of shares available for awards under the incentive plan, which was obtained on September 27, 2012.

Issuer

EnteroMedics Inc

CIK 0001371217

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001371217

Filing Metadata

Form type
4
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:26 PM ET
Size
27.2 KB